Stock Market Update

[BRIEFING.COM] The S&P 500 (+0.20%) is in second place on Tuesday afternoon, up about 11 points.

Elsewhere, S&P 500 constituents Insulet (PODD 195.43, +14.74, +8.16%), Resmed (RMD 239.90, +14.04, +6.22%), and Norwegian Cruise Line (NCLH 18.30, +0.85, +4.87%) dot the top of the standings. PODD gains on earlier-than expected FDA approval for Omnipod 5 for type 2 diabetes, while RMD caught a bullish analyst note related to weight loss drug prospects, with NCLH and its peers higher despite a dearth of corporate news.

Meanwhile, Walgreens Boots Alliance (WBA 9.54, -0.84, -8.09%) is today's top laggard, losses due in part to waning pharmacy sentiment after Pfizer (PFE 28.81, -0.11, -0.38%) launched its pfizerforall.com platform and Eli Lilly (LLY 954.68, +4.15, +0.44%) released DTC Zepbound single-dose vials.